Searchable abstracts of presentations at key conferences in endocrinology

ea0037oc12.1 | Pituitary – Clinical | ECE2015

The Irish TSHoma study: a multicentre retrospective study

Pazderska Agnieszka , Cuesta Martin , Wallace Helen , Melvin Audrey , Gibney James , Agha Amar , O'Halloran Donal , Hunter Steven , Thompson Chris , Sherlock Mark

TSH-secreting pituitary adenomas (TSHomas) are rare. Previously, the reported prevalence was one case per million populations although this is probably an underestimate. A recently published study reported a prevalence of TSHomas in Sweden of 2.8/million inhabitants.Methods/design: Observational study conducted in four tertiary referral centres in Ireland. We retrospectively collected data on the prevalence, demographics, hormonal profile, tumour charact...

ea0056p36 | Adrenal cortex (to include Cushing's) | ECE2018

Hypoaldosteronism induced by trimethroprim: hyponatremia is frequent

Herraiz Lorea , Azcutia Ane , Santiago Alejandro , Miguel Paz de , Crespo Irene , Cuesta Martin , Jimenez Ines , Calle Alfonso , Runkle Isabelle

Introduction: Hypoaldosteronism is characterized by the development of hyperkalemia, but can also induce hypovolemic hyponatremia. Trimethroprim can cause hypoaldosteronism through mineralocorticoid resistance. That hypoaldosteronism can induce hyponatremia in absence of Addison’s disease has been questioned. We studied the electrolyte disturbances found following initiation of trimetroprim therapy.Material and methods: Retrospective, analytical. La...

ea0063p111 | Calcium and Bone 1 | ECE2019

The coincidence of primary hyperparathyroidism and primary hyperaldosteronism is not infrequent: a retrospective case analysis

Barrio Elvira , Ramos Elvira , Crespo Irene , Pallares Raquel , Pazos Mario , de Miguel Paz , Cuesta Martin , Jose Torrejon Maria , Calle Alfonso , Runkle Isabelle

Introduction: Primary hyperparathyroidism (PHP) has been postulated to be a cause of primary hyperaldosteronism (PHA). In fact, PTH receptors have been detected in aldosteronoma tissue. Hyperaldosteronism can also induce elevation of PTH levels, as increased circulating volume increases calciuria, with secondary elevation of PTH levels as serum calcium levels rise. We studied the prevalence of PHP in a group of patients diagnosed with PHA either following or simultaneously wit...

ea0063p649 | Interdisciplinary Endocrinology 1 | ECE2019

Polydispia can reveal underlying non-osmotic arginine-vasopressin secretion

Pazos Mario , Pallares Raquel , Cuesta Martin , Barrio Elvira , Ramos Elvira , Herraiz Lorea , Azcutia Ane , Miguel Maria Paz De , Runkle Isabelle , Calle Alfonso

Inroduction: Polydipsia -excessive oral intake of liquids, with/without thirst- can induce euvolemic hyponatremia. Adequate inhibition of AVP secretion induced by low plasma osmolality (POsm) is reflected in a urinary osmolality (UOsm) ≤100 mOsm/kg. However, increased fluid intake can also reveal underlying non-osmotic AVP secretion, induced by pain, nausea, and/or SIADH, with UOsm >100. Iatrogenic polydipsia is characterized by increased liquid intake without thirst...

ea0063p850 | Adrenal and Neuroendocrine Tumours 3 | ECE2019

Measurement of androstenedione levels in adrenal veins for calculation of the selectivity index in adrenal venous sampling

Miren Azcutia Ane , Angelica Herraiz Lorea , Gonzalez Natalia , Jurado Purificacion , Abad Maria , Cuesta Martin , Mendez Jose , Calle Alfonso , Jose Torrejon Maria , Runkle Isabelle

Introduction: Primary hyperaldosteronism (PH) is characterized by autonomous adrenal aldosterone (A) hypersecretion. Unilateral adrenalectomy is the treatment of choice, when adrenal vein sampling (AVS) indicates lateralization of A secretion. To assure that each adrenal vein (AV) has been correctly sampled, cortisol levels in each adrenal vein must be higher than in the inferior vena cava. The adrenal gland cortisol/vena cava cortisol ratio is referred to as the selectivity i...

ea0041ep597 | Endocrine tumours and neoplasia | ECE2016

Phaeochromocytomas and paragangliomas: A comparative study between sporadic and familial cases in a reference care center in Spain

Luis Guillermo Ropero , Perez Jose Angel Diaz , Gracia Teresa Ruiz , Hernandez Martin Cuesta , Hoyos Emilia Gomez , Hernandez Irene Crespo , Novoa Paz de Miguel

Introduction: Hereditary phaeochromocytoma (PCC) and paraganglioma (PGL) account for 30–35% of cases and have some clinically relevant peculiarities.Material and methods: Retrospective, unicentric cohort study that included all genotyped patients (n=36, 27 with PCC and 9 with PGL) diagnosed at Hospital Clínico San Carlos (Madrid) between 1984 and 2013; 33% were germline mutation carriers (25% pseudohypoxic [PH] phenotype, 75% MAP-kinas...

ea0041ep603 | Endocrine tumours and neoplasia | ECE2016

Medullary Thyroid Cancer: a comparative study between sporadic and familial cases in a reference care center in Spain

Luis Guillermo Ropero , Perez Jose Angel Diaz , Hoyos Emilia Gomez , Hernandez Martin Cuesta , Hernandez Irene Crespo , Gracia Teresa Ruiz , de Miguel Novoa Paz

Introduction: Hereditary Medullary Thyroid Cancer (MTC) accounts for 20–30% of cases and has some clinically relevant peculiarities.Material and methods: Retrospective, unicentric cohort study that included all genotyped patients with MTC (n=48) diagnosed at Hospital Clínico San Carlos (Madrid) between 1984–2013; 42% were germline mutation carriers (45% moderate risk (category MOD), 45% high risk (category H), 10% highest risk (ca...

ea0041ep742 | Neuroendocrinology | ECE2016

How frequently can we predict failure of fluid restriction in SIAD? Results of a multicenter prospective audit

Cuesta Martin , Ortola Ana , Slattery 2David , Garrahy Aoife , Pascual Alfonso Luis Calle , Tormey William , de la Vega Isabelle Runkle , Thompson Christopher J.

Context: Fluid restriction (FR) is recommended as first line therapy for SIAD by both the European1 and the American guidelines2 for management of SIAD. Not all patients respond to FR however, and the American guidelines have identified clinical predictors of failure to respond to FR. These include 1.Urine osmolality (UOsm) >500 mOsm/Kg 2. Furst formula (ratio UNa+UK/pNa) > 1, and 3. 24 hour-urine volume<1500 mlObjective...

ea0037gp.03.05 | Adrenal (2) | ECE2015

Short-term blood pressure response to mineralocorticoid-receptor blockade in aldosteronisms: primary hyperaldosteronism vs aldosterone-associated hypertension/low-renin hypertension

Crespo Irene , Ruiz-Gracia Teresa , Ortola Ana , Gomez-Hoyos Emilia , Cuesta Martin , Barabash Ana , Saez-de Parayuelo Maria Victoria , Sanchez-Orta Marisol , Calle-Pascual Alfonso , Runkle Isabelle

Introduction: Some authors consider aldosteronism to be a spectrum, ranging from aldosterone-associated (or low-renin) hypertension (AAH) to primary hyperaldosteronism (PHA) due to bilateral adrenal hyperplasia. Thus, blood pressure (BP) response to mineralocorticoid-receptor blockade (MRB) could be similar.Methods: Retrospective analysis of 60 patients. Screening per Endocrine Society guidelines, positive screening: aldosterone (pg/ml) to direct-renin (...

ea0037ep672 | Pituitary: basic and neuroendocrinology | ECE2015

The use of an oral salt load followed by furosemide in the treatment of euvolemic SIADH-induced hyponatremia

Ortola Ana , Crespo Irene , Ruiz-Gracia Teresa , Gomez-Hoyos Emilia , Cuesta Martin , Penso Rona , Amengual Angela , de Miguel Paz , Calle-Pascual Alfonso , Runkle Isabelle

Introduction: Furosemide can be used in the treatment of SIADH. However, to be effective, renal medulla osmolality (OsmRM) as reflected in urinary osmolality (UOSM) must be high. Sodium is the most important contributor to OsmRM, which increases following the administration of oral salt. We analyze the use of an oral salt load followed by furosemide for the acute/short-term treatment of euvolemic SIADH hyponatremia.Method...